Yorke Justin W
- SEC CIK
- 0001361896
No open-market purchases or sales filed in the past year.
Current role at each company
- PCSA Processa Pharmaceuticals, Inc.Directoras of Jul 28, 2026
- EDVA Endovia Health Sciences, Inc.Directoras of Oct 15, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yorke Justin W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCSA Processa Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 (view filing) | Dec 3-6 | 4 days | Yorke Justin WDirector | SSale | −9.70K | $4.78 | −$46.4K | −1.8%534.4K after | 2 lots |
| Jan 31, 2022 (view filing) | Jan 27 | 4 days | Yorke Justin WDirector | SSale | −1.85K | $3.30 | −$6.12K | −0.3%532.6K after | |
| Jan 31, 2024 (view filing) | Jan 30 | 1 day | Yorke Justin WDirector | PPurchase | +8.00K | $2.69 | +$21.5K | +34.4%31.2K after |